Welcome to our dedicated page for LOGIQ news (Ticker: LGIQ), a resource for investors and traders seeking the latest updates and insights on LOGIQ stock.
Logiq, Inc. develops e-commerce, m-commerce, marketing technology, and fintech solutions for mobile users. The company provides AppLogiq, a platform that enables SMBs to create native mobile apps in multiple languages across various markets. Their AI-driven data engine, DataLogiq, captures consumer intent to boost leads, engagement, and conversion. Additionally, Logiq offers LogiqX for consumer insights, PayLogiq for mobile payments, and GoLogiq for food delivery. With a focus on digital customer acquisition, Logiq simplifies digital advertising and delivers data-driven marketing solutions.
Logiq, Inc. (OTC PINK:LGIQ) has announced a definitive agreement to acquire EVIMATE, a medical device innovation company, for $5 million. This acquisition marks Logiq's entry into the medical device sector. EVIMATE specializes in advanced vital sign monitoring products that utilize AI technology for comprehensive health metric tracking and predictive analytics.
EVIMATE's solution includes next-generation devices and a user-friendly app that continuously monitors key health indicators such as temperature, heart rate, ECG, blood pressure, oxygen levels, and glucose levels. The system is designed for Remote Patient Monitoring (RPM), providing real-time insights and alerts to healthcare providers, caregivers, and family members.
Additionally, EVIMATE has developed an automotive healthcare system for monitoring driver vitals, featuring sensors in the driver's seat and steering wheel to collect vital signs like heart functions, respiratory rate, stress level, and blood oxygen level. All devices mentioned will require FDA regulatory approvals and additional patent filings for IP protection.
Logiq, Inc. (OTC:LGIQ) has announced a definitive agreement to acquire MedLab Essentials, , a leader in cell and gene therapy innovation, in a deal valued at $100 million. The acquisition will be executed through a share exchange, with MedLab becoming a wholly owned subsidiary of Logiq. Key highlights include:
1. Logiq shareholders will retain 15% post-transaction
2. The combined entity aims to uplist to Nasdaq, CBOE, or NYSE
3. A substantial capital raise is planned by the end of 2024
4. This marks Logiq's first step in a series of biotech acquisitions targeting a cumulative value over $750 million
This strategic move signifies Logiq's diversification into the biotech sector, particularly focusing on cell and gene therapy assets.
Logiq has signed a binding letter of intent to acquire MedLab Essentials for $100 million in a share exchange deal. MedLab will become a wholly-owned subsidiary, with its executives joining Logiq's senior management.
This acquisition diversifies Logiq into the biotech sector and aims for a Nasdaq, CBOE, or NYSE uplisting by Q3 2024. Post-transaction, Logiq shareholders will retain 15% of the company. This is part of a broader strategy to expand into biotech and cell and gene therapy, targeting a cumulative value exceeding $750 million.
Logiq, Inc. (OTCQX: LGIQ) has announced the acquisition of Park Place Payments, a fintech company specializing in merchant payment solutions. This all-stock transaction is valued at over $6 million, contingent upon meeting specific milestones. Park Place operates within the gig economy, boasting more than 1,500 account executives and generating over $5 million in revenue with an annualized transaction volume exceeding $180 million. The acquisition is expected to enhance Logiq's digital marketing capabilities and expand its fintech offerings to a broader array of small businesses. Park Place aims to grow its sales team to 40,000 executives in the coming years, potentially yielding $15 million in additional revenue for Logiq within a year. This strategic move aligns with Logiq's ongoing M&A strategy to enhance its direct-to-consumer and B2B business model.
FAQ
What is the current stock price of LOGIQ (LGIQ)?
What is the market cap of LOGIQ (LGIQ)?
What solutions does Logiq, Inc. provide?
What is AppLogiq?
What is DataLogiq?
What are the key products offered by Logiq?
Where is Logiq, Inc. headquartered?
What does Logiq focus on in terms of digital advertising?
What is the recent strategic acquisition by Logiq?
What is the estimated value of the acquisition?
What are the anticipated outcomes of the MedLab acquisition?